govdashboard.fda.govFDA Data Dashboard | FDA

Skip to main content Skip to FDA Search Skip to in this section menu Skip to footer links An official website of the United States government Here’s how you know The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. U.S. Food and Drug Administration Search Menu Search FDA Submit search Featured Contact FDA FDA Guidance Documents Recalls, Market Withdrawals and Safety Alerts Press Announcements Warning Letters Advisory Committees En Español Products Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood, and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International Programs News and Events Training and Continuing Education Inspections and Compliance Science and Research Information For Consumers Patients Industry Health Professionals Federal, State and Local Officials In this section : Transparency FDA Data Dashboard Home About FDA Transparency FDA Data Dashboard Transparency FDA Data Dashboard Share Tweet Linkedin Email Print On this page: About the FDA Data Dashboard Tools for Using the Dashboard More Information About FDA Inspection and Compliance Data Contact Us Access the Data Dashboard About the FDA Data Dashboard On January 21, 2009, President Obama issued the Memorandum on Transparency and Open Government instructing agencies to take specific actions to implement the principles of transparency, participation, and collaboration. To that end, the FDA has since published various datasets to include compliance data on FDA.gov. In addition to disclosing new data, the FDA has explored several methods to display data, increase usability, and improve the overall user experience. The Data Dashboard is designed to support the understanding, accountability, and analysis of public FDA data through easy to use, visually accessible, customizable, and understandable graphics. The underlying data used to generate the dashboard graphs are based upon transparency datasets and other data already available to the public through FDA.gov. The current datasets and data include the Inspection Database and selected data elements from the compliance, enforcement, and import related information on FDA.gov. The Dashboard may expand to incorporate future datasets based upon need and user feedback. Tools for Using the Dashboard Glossary Inspectional and compliance data are refreshed on a weekly basis and only include final actions. Please note each individual dashboard page provides information pertaining to the data displayed. The caveats and disclaimers provide guidance on the data being reported, data limitations and information on what the data represents. All source data used to create the graphical representations are pulled from FDA’s transactional systems and subject to change. More Information About FDA Inspection and Compliance Data You may find the location and additional information about each dataset and other data sources by clicking on the links below: Inspections Database ORA FOIA Electronic Reading Room Warning Letters Recalls Recall data used in this dashboard were based upon the Enforcement Statistics PDFs. For more detailed information about individual recalls, please see: Enforcement Reports Recalls, Market Withdrawals & Safety Alerts Import Program Resources Please note that each individual dashboard page provides information pertaining to the data provided. These caveats provide guidance on the data being reported, data limitations and information on what the data represents. Additionally the following information is provided in an effort to enhance the user experience and define data limitations. All underlying data used to create the graphical representations are pulled from FDA’s transactional systems and are subject to change. Inspections and related data disclosed include completed and finalized inspections of clinical trial investigators, Institutional Review Boards (IRB), and facilities that manufacture, process, pack, or hold an FDA-regulated product that is currently marketed. Compliance data provides information on a subset of the actions used by the FDA to bring firms into compliance, specifically data pertaining to Warning Letters, Seizures, and Injunctions. The compliance actions disclosed include only finalized and completed actions and are primarily used in the domestic arena. Actions pertaining to foreign firms often take the form of import alerts, and are currently not reported in this Dashboard release. Contact Us Questions and Comments pertaining to the FDA Data Dashboard and source data may be directed by email to: FDADataDashboard@fda.hhs.gov . Content current as of: 02/24/2021 FDA Data Dashboard Footer Links FDA Archive About FDA Accessibility Visitor Information Website Policies / Privacy No FEAR Act FOIA HHS.gov USA.gov Contact FDA Follow FDA on Facebook Follow FDA on Twitter View FDA videos on YouTube Subscribe to FDA RSS feeds FDA Homepage Contact Number 1-888-INFO-FDA (1-888-463-6332) Back to Top...